Cargando…
Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke
BACKGROUND: Mesenchymal stem cells (MSCs) hold great potential as a therapy for stroke and have previously been shown to promote recovery in preclinical models of cerebral ischaemia. MSCs secrete a wide range of growth factors, chemokines, cytokines and extracellular vesicles—collectively termed the...
Autores principales: | Cunningham, Catriona J., Wong, Raymond, Barrington, Jack, Tamburrano, Sabrina, Pinteaux, Emmanuel, Allan, Stuart M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975095/ https://www.ncbi.nlm.nih.gov/pubmed/31964413 http://dx.doi.org/10.1186/s13287-020-1560-y |
Ejemplares similares
-
Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming
por: Redondo-Castro, Elena, et al.
Publicado: (2018) -
Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro
por: Redondo-Castro, Elena, et al.
Publicado: (2017) -
Pentraxin 3 promotes long-term cerebral blood flow recovery, angiogenesis, and neuronal survival after stroke
por: Rajkovic, Ivana, et al.
Publicado: (2018) -
Therapeutic potential of extracellular vesicles in preclinical stroke models: a systematic review and meta-analysis
por: Thomas, Josephine M, et al.
Publicado: (2020) -
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
por: Cunningham, Catriona J, et al.
Publicado: (2018)